Journal of Shanghai Jiao Tong University (Medical Science) >
Multi-omics analysis of methylmalonic acidemia caused by a non-coding region variant in MMAA gene combined with uniparental disomy
Received date: 2024-11-06
Accepted date: 2025-03-05
Online published: 2025-06-23
Supported by
National Key R&D Program of China(2022YFC2703405);National Natural Science Foundation of China(82171165)
Objective ·To investigate the genetic etiology of a rare and complex case clinically suspected to be methylmalonic acidemia (MMA), but with negative whole exome sequencing (WES) results, using a multi-omics sequencing approach. Methods ·DNA and RNA samples were extracted from the peripheral blood of the proband and both parents. Targeted MMA-related gene Panel sequencing and WES were first performed. Subsequently, RNA sequencing (RNA-seq) and whole genome sequencing (WGS) were conducted to comprehensively analyze the child's genetic variants, their origins and potential inheritance patterns. Results ·No pathogenic variants associated with the patient's phenotype were identified through the MMA Panel or standard WES analysis. Extended analysis of WES suggested the possibility of uniparental disomy (UPD) of chromosome 4. WGS revealed a homozygous splice-site variant (c.-66+2T>C) in the non-coding region of the metabolism of cobalamin associated A (MMAA) gene. The variant was located in the 5' untranslated region (5'UTR), specifically at the second base downstream of the splice donor site of exon 1 (reference sequence: NM_172250). In genomic coordinates (hg19), the variant was located at base 146540561 on chromosome 4 (chr4:146540561). Sanger sequencing confirmed that the mother was heterozygous for this variant, while the father did not carry it. RNA-seq showed no detectable expression of the MMAA gene on chromosome 4 in the patient. This was further confirmed by reverse transcription real time quantitative PCR, indicating nearly absent mRNA expression, suggesting that the non-coding splice-site variant affected transcriptional expression. Conclusion ·A homozygous splice-site variant (c.-66+2T>C) in the non-coding region of the MMAA gene—outside the coverage of WES—is likely the pathogenic cause in this case, presumably resulting from maternal UPD of chromosome 4.
HUO Xiaoyan , LUO Xiaomei , YE Xiantao , SUN Yu , YU Yongguo , LIANG Lili , FAN Yanjie . Multi-omics analysis of methylmalonic acidemia caused by a non-coding region variant in MMAA gene combined with uniparental disomy[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025 , 45(6) : 800 -806 . DOI: 10.3969/j.issn.1674-8115.2025.06.016
[1] | HAENDEL M, VASILEVSKY N, UNNI D, et al. How many rare diseases are there?[J]. Nat Rev Drug Discov, 2020, 19(2): 77-78. |
[2] | CHUNG C C Y, HUE S P Y, NG N Y T, et al. Meta-analysis of the diagnostic and clinical utility of exome and genome sequencing in pediatric and adult patients with rare diseases across diverse populations[J]. Genet Med, 2023, 25(9): 100896. |
[3] | WHIFFIN N, KARCZEWSKI K J, ZHANG X L, et al. Characterising the loss-of-function impact of 5' untranslated region variants in 15 708 individuals[J]. Nat Commun, 2020, 11(1): 2523. |
[4] | BAUWENS M, GARANTO A, SANGERMANO R, et al. ABCA4-associated disease as a model for missing heritability in autosomal recessive disorders: novel noncoding splice, cis-regulatory, structural, and recurrent hypomorphic variants[J]. Genet Med, 2019, 21(8): 1761-1771. |
[5] | WAI H A, LORD J, LYON M, et al. Blood RNA analysis can increase clinical diagnostic rate and resolve variants of uncertain significance[J]. Genet Med, 2020, 22(6): 1005-1014. |
[6] | JONES S A, CANTSILIERIS S, FAN H P, et al. Rare variants in non-coding regulatory regions of the genome that affect gene expression in systemic lupus erythematosus[J]. Sci Rep, 2019, 9(1): 15433. |
[7] | MURDOCK D R, DAI H Z, BURRAGE L C, et al. Transcriptome-directed analysis for Mendelian disease diagnosis overcomes limitations of conventional genomic testing[J]. J Clin Invest, 2021, 131(1): e141500. |
[8] | CUMMINGS B B, MARSHALL J L, TUKIAINEN T, et al. Improving genetic diagnosis in Mendelian disease with transcriptome sequencing[J]. Sci Transl Med, 2017, 9(386): eaal5209. |
[9] | HEAD P E, MEIER J L, VENDITTI C P. New insights into the pathophysiology of methylmalonic acidemia[J]. J Inherit Metab Dis, 2023, 46(3): 436-449. |
[10] | BAUMGARTNER M R, H?RSTER F, DIONISI-VICI C, et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia[J]. Orphanet J Rare Dis, 2014, 9: 130. |
[11] | RICHARDS S, AZIZ N, BALE S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. |
[12] | DUDNYK K, CAI D H, SHI C L, et al. Sequence basis of transcription initiation in the human genome[J]. Science, 2024, 384(6694): eadj0116. |
[13] | LERNER-ELLIS J P, DOBSON C M, WAI T, et al. Mutations in the MMAA gene in patients with the cblA disorder of vitamin B12 metabolism[J]. Hum Mutat, 2004, 24(6): 509-516. |
[14] | LAVELLE T A, FENG X, KEISLER M, et al. Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions[J]. Genet Med, 2022, 24(6): 1349-1361. |
[15] | FERRARO N M, STROBER B J, EINSON J, et al. Transcriptomic signatures across human tissues identify functional rare genetic variation[J]. Science, 2020, 369(6509): eaaz5900. |
[16] | DAMGAARD C K, KAHNS S, LYKKE-ANDERSEN S, et al. A 5' splice site enhances the recruitment of basal transcription initiation factors in vivo[J]. Mol Cell, 2008, 29(2): 271-278. |
[17] | ROBINSON W P. Mechanisms leading to uniparental disomy and their clinical consequences[J]. Bioessays, 2000, 22(5): 452-459. |
[18] | BASU M, WANG K, RUPPIN E, et al. Predicting tissue-specific gene expression from whole blood transcriptome[J]. Sci Adv, 2021, 7(14): eabd6991. |
/
〈 |
|
〉 |